Piper Sandler analyst Charles Neivert lowered the firm’s price target on Albemarle to $90 from $95 and keeps an Underweight rating on the shares. The firm has updated its Albemarle model to reflect Q2 results, new company guidance and its own recent channel checks. Lithium prices continue to slide on a global basis as new capacity significantly outpaces demand growth, Piper adds. The firm expects this condition to remain a headwind for lithium pricing and lithium shares for the next 12 to 18 months.
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ALB:
- Albemarle price target lowered to $85 from $135 at Scotiabank
- Albemarle price target lowered to $111 from $128 at RBC Capital
- Albemarle price target lowered to $132 from $151 at KeyBanc
- Albemarle downgraded to Neutral from Outperform at Baird
- Albemarle price target lowered to $102 from $127 at Baird